Search
for
Sort by
Research 31–60 of 335
- Semaglutide and the Skin: An Overview of Current Evidence
- Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Farmácia Avenida Brasil, Porto
- Metabolic syndrome — a new definition and management guidelines
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Clinical aspects of the metabolic syndrome
- Debatable Topics in PCOS Patients
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Understanding Polycystic Ovary Syndrome
- Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique